XK
Basic information
Region (hg38): X:37685791-37732130
Previous symbols: [ "NA", "NAC" ]
Links
Phenotypes
GenCC
Source:
- McLeod neuroacanthocytosis syndrome (Strong), mode of inheritance: XL
- McLeod neuroacanthocytosis syndrome (Supportive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
McLeod syndrome | XL | Cardiovascular | Surveillance for cardiovascular disease (eg, dilated cardiomyopathy and arrhythmias) and early medical treatment may reduce morbidity | Cardiovascular; Hematologic; Musculoskeletal; Neurologic | 13860532; 8004674; 11261514; 11761473; 17683354; 21463873 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the XK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 21 | ||||
missense | 27 | 30 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 2 | 2 | 28 | 14 | 11 |
Variants in XK
This is a list of pathogenic ClinVar variants found in the XK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-37686018-G-C | Benign (Oct 04, 2023) | |||
X-37686032-T-A | Uncertain significance (Apr 12, 2022) | |||
X-37686046-C-G | McLeod neuroacanthocytosis syndrome | Uncertain significance (Sep 19, 2022) | ||
X-37686061-C-G | McLeod neuroacanthocytosis syndrome | Uncertain significance (Jun 14, 2022) | ||
X-37686066-G-A | Inborn genetic diseases | Uncertain significance (Feb 12, 2024) | ||
X-37686069-G-T | not specified | Uncertain significance (Mar 01, 2024) | ||
X-37686111-C-T | Benign (Jan 26, 2024) | |||
X-37686132-C-G | Uncertain significance (Mar 01, 2022) | |||
X-37686137-A-G | Uncertain significance (Dec 20, 2022) | |||
X-37686138-C-G | Inborn genetic diseases | Uncertain significance (Jan 19, 2024) | ||
X-37686161-C-T | McLeod neuroacanthocytosis syndrome | Uncertain significance (Jan 01, 2023) | ||
X-37686165-C-T | Likely benign (Aug 26, 2022) | |||
X-37686166-G-T | Uncertain significance (Jun 18, 2023) | |||
X-37686171-G-C | XK-related disorder | Likely benign (Jul 23, 2024) | ||
X-37686189-A-G | Likely benign (Oct 25, 2022) | |||
X-37686204-C-G | Uncertain significance (Nov 19, 2023) | |||
X-37694278-G-C | Likely benign (Dec 15, 2023) | |||
X-37694314-C-T | XK-related disorder | Likely pathogenic (Dec 06, 2023) | ||
X-37694337-T-A | Likely benign (Oct 13, 2023) | |||
X-37694343-C-T | Likely benign (Aug 24, 2023) | |||
X-37694375-A-G | McLeod neuroacanthocytosis syndrome | Uncertain significance (Sep 21, 2021) | ||
X-37694383-T-C | Uncertain significance (Oct 18, 2022) | |||
X-37694393-T-C | Inborn genetic diseases | Uncertain significance (Feb 17, 2022) | ||
X-37694437-C-T | Pathogenic (Aug 09, 2023) | |||
X-37694444-C-T | McLeod neuroacanthocytosis syndrome | Uncertain significance (Jul 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
XK | protein_coding | protein_coding | ENST00000378616 | 3 | 46372 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.954 | 0.0462 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.12 | 88 | 165 | 0.534 | 0.0000113 | 2892 |
Missense in Polyphen | 26 | 67.343 | 0.38608 | 1187 | ||
Synonymous | -0.633 | 80 | 73.1 | 1.09 | 0.00000542 | 907 |
Loss of Function | 2.88 | 0 | 9.65 | 0.00 | 6.68e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in sodium-dependent transport of neutral amino acids or oligopeptides.;
- Disease
- DISEASE: McLeod syndrome (MLS) [MIM:300842]: A multisystem disorder characterized by the absence of red blood cell Kx antigen, weak expression of Kell red blood cell antigens, acanthocytosis, and compensated hemolysis. Most carriers of this McLeod blood group phenotype have acanthocytosis and elevated serum creatine kinase levels and are prone to develop a severe neurologic disorder resembling Huntington disease. Additional symptoms include generalized seizures, neuromuscular symptoms leading to weakness and atrophy, and cardiomyopathy mainly manifesting with atrial fibrillation, malignant arrhythmias, and dilated cardiomyopathy. {ECO:0000269|PubMed:11761473, ECO:0000269|PubMed:11961232, ECO:0000269|PubMed:12823753}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.76
Haploinsufficiency Scores
- pHI
- 0.552
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.881
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Low | Medium |
Mouse Genome Informatics
- Gene name
- Xk
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; muscle phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- amino acid transport;cellular calcium ion homeostasis;regulation of cell size;cellular magnesium ion homeostasis;regulation of axon diameter;myelination;skeletal muscle fiber development
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- transporter activity;protein binding